Yayue Zhang
Overview
Explore the profile of Yayue Zhang including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
10
Citations
43
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Yun Z, Liu Z, Shen Y, Sun Z, Zhao H, Du X, et al.
Comput Biol Med
. 2024 Aug;
181:109064.
PMID: 39216403
Background: Clinical therapeutic targets for leukemia remain to be identified and the causality between leukemia and telomere length is unclear. Methods: This work employed cis expression quantitative trait locus (eQTL)...
2.
Yan X, Zhang Y, Lang H, Huang Z, Chen X, He H, et al.
Eur J Med Res
. 2023 Feb;
28(1):67.
PMID: 36750876
Rationale: Immune thrombocytopenia (ITP) is thought to be a result of immune dysfunction, which is treated by glucocorticoids such as prednisone. Vasoactive intestinal peptide (VIP) and pituitary adenylate cyclase activating...
3.
Zheng Z, Liu P, Xu L, Peng Z, Zhang Y, Chen X, et al.
RSC Adv
. 2022 May;
8(26):14445-14453.
PMID: 35540790
Acute myeloid leukemia (AML) is a group of hematological malignancies causing high mortality around the world. However, the treatment of AML is still one of the most formidable challenges. In...
4.
Zhang Y, Sung A, Rubinstein E, Benigno M, Chambers R, Patino N, et al.
BMC Infect Dis
. 2022 Feb;
22(1):154.
PMID: 35164701
Background: Invasive mucormycosis (IM) is a rare and often life-threatening fungal infection, for which clinical and epidemiological understanding is lacking. Electronic health record (EHR) data can be utilized to elucidate...
5.
Zhang Y, Jiang M, Wang J, Gao J, Guo M, Liu J, et al.
Ann Palliat Med
. 2021 May;
10(4):4612-4622.
PMID: 33966409
Background: To explore the effect mechanism of "treat the spleen" therapy on immune thrombocytopenia (ITP) based on the characteristics of vasoactive factors. Methods: The ITP mice model was established by...
6.
Zhang Y, Wang J, Gao J, Guo M, Chen H, Liu J, et al.
Ann Palliat Med
. 2021 Jan;
10(1):156-168.
PMID: 33440960
Background: Immune thrombocytopenia (ITP) is a heterogeneous autoimmune disease characterized by platelet destruction. In previous studies, Jianpi Yiqi Shexue (JPYQSX) was shown to increase the peripheral platelet (PLT) counts in...
7.
Lv P, Zhang Z, Hou L, Zhang Y, Lu L, Wang C, et al.
Biosci Rep
. 2020 Sep;
40(9).
PMID: 32869851
Low expression of tumor suppressor microRNA (miRNA) and high expression of carcinogenic miRNA promote the occurrence and progression of human cancer. Most studies show that miR-145 is a tumor suppressor...
8.
Wang J, Li Y, Wang C, Zhang Y, Gao C, Lang H, et al.
Biomed Res Int
. 2019 Jan;
2018:1316096.
PMID: 30648105
To conduct a meta-analysis, assessing the efficacy and safety of the combination treatment of dexamethasone and rituximab for adults with ITP (primary immune thrombocytopenia). Randomized controlled trials that compared rituximab...
9.
Qi S, Lai H, Zhang Y, Dong Q, Zhu X
Medicine (Baltimore)
. 2018 Oct;
97(39):e12594.
PMID: 30278572
Background: Opioid induced constipation (OIC) is a symptom that is commonly encountered in cancer pain management. Chinese herbal medicine (CHM) has been widely used to improve OIC in China. Many...
10.
Gao C, Wang J, Li Y, Zhao H, Li R, Hou L, et al.
Medicine (Baltimore)
. 2018 Aug;
97(34):e11860.
PMID: 30142779
Background: Hypomethylating agents (HMAs) are believed to have reliable efficacy in treating myelodysplastic syndromes (MDS) and acute myeloid leukemia (AML). Meanwhile, the adverse events of HMAs have become an increasing...